MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakada, M. T.
Right arrow Articles by Crooke, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakada, M. T.
Right arrow Articles by Crooke, S. T.

Glucocorticoid regulation of beta-adrenergic receptors in 3T3-L1 preadipocytes

MT Nakada, JM Stadel, KS Poksay and ST Crooke

Treatment of 3T3-L1 preadipocytes (fibroblasts) with 250 nM dexamethasone for 48 hr caused a doubling of total beta-adrenergic receptors and an increase in beta 2-adrenergic receptor subtype proportion from approximately 50% in controls to 85% in treated cells. The responses to epinephrine and norepinephrine in a whole cell cAMP accumulation assay reflected these changes. The effects of dexamethasone on beta-adrenergic receptors were mediated through the glucocorticoid receptor and were time and dose dependent with an EC50 of 2.77 +/- 0.73 nM for an increase in the proportion of beta 2- adrenergic receptors. The rank order of potency of steroids to effect these changes (betamethasone = dexamethasone greater than fludrocortisone greater than hydrocortisone = triamcinolone greater than aldosterone) correlated with their glucocorticoid potency. [3H]Dexamethasone binding to intact cells yielded a KD value of 3.47 +/- 0.38 nM for binding to the glucocorticoid receptor which correlated well with the EC50 for dexamethasone to alter beta-adrenergic receptors. Inhibition of [3H]dexamethasone binding by other steroids confirmed that the ability of steroids to regulate beta-adrenergic receptors correlated with the affinity of each compound for the 3T3-L1 glucocorticoid receptor. Progesterone, which can bind to the glucocorticoid receptor but has only weak agonist activity, competitively inhibited the ability of dexamethasone to alter beta- adrenergic receptors. Protein synthesis, RNA synthesis, and N-linked glycosylation appeared to be necessary for the change in receptor subtype expression and the increase in beta-adrenergic receptor number induced by dexamethasone. The present study suggests that regulation of beta-adrenergic receptor expression in 3T3-L1 preadipocytes by dexamethasone is a glucocorticoid-specific effect which may require gene activation.

Volume 31, Issue 4, pp. 377-384, 04/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J EndocrinolHome page
D. P Macfarlane, S. Forbes, and B. R Walker
Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome
J. Endocrinol., May 1, 2008; 197(2): 189 - 204.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R H Straub, R Wiest, U G Strauch, P Harle, and J Scholmerich
The role of the sympathetic nervous system in intestinal inflammation.
Gut, November 1, 2006; 55(11): 1640 - 1649.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
P Harle, R H Straub, R Wiest, A Mayer, J Scholmerich, F Atzeni, M Carrabba, M Cutolo, and P Sarzi-Puttini
Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems
Ann Rheum Dis, January 1, 2006; 65(1): 51 - 56.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
R H Straub, F Buttgereit, and M Cutolo
Benefit of pregnancy in inflammatory arthritis
Ann Rheum Dis, June 1, 2005; 64(6): 801 - 803.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Villena, S. Roy, E. Sarkadi-Nagy, K.-H. Kim, and H. S. Sul
Desnutrin, an Adipocyte Gene Encoding a Novel Patatin Domain-containing Protein, Is Induced by Fasting and Glucocorticoids: ECTOPIC EXPRESSION OF DESNUTRIN INCREASES TRIGLYCERIDE HYDROLYSIS
J. Biol. Chem., November 5, 2004; 279(45): 47066 - 47075.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. H. STRAUB, C. GUNZLER, L. E. MILLER, M. CUTOLO, J. SCHOLMERICH, and S. SCHILL
Anti-inflammatory cooperativity of corticosteroids and norepinephrine in rheumatoid arthritis synovial tissue in vivo and in vitro
FASEB J, July 1, 2002; 16(9): 993 - 1000.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Fève, F. Piétri-Rouxel, K. E. Hadri, M.-F. Drumare, and A. D. Strosberg
Long Term Phorbol Ester Treatment Down-regulates the [IMAGE][IMAGE]-Adrenergic Receptor in 3T3-F442A Adipocytes
J. Biol. Chem., May 5, 1995; 270(18): 10952 - 10959.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1987 by the American Society for Pharmacology and Experimental Therapeutics